Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$501,769
+$113,560 QoQ
Shares Held
5,890
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#309
of 480 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $261,404,130 across 8 Biotechnology names. CYTK ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,718 | $104,669,952 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,076,063 | $60,334,852 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
175,542 | $50,024,203 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
58,080 | $17,483,822 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,458 | $15,874,081 | |
| 6 | ASND |
Ascendis Pharma A/S
|
26,222 | $6,993,931 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
101,238 | $5,521,520 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
5,890 | $501,769 |
All Filings in CYTK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $501,769 | 5,890 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $388,209 | 5,890 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||